|
Design Feature:
|
(1) Circles
(2) One circle or ellipse
(3) Letters presenting a special form of writing
(4) Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.
|
|
Description:
|
(1) - Biological preparations for use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely vaccines for use in gene therapy; all the aforementioned wares exclusively in the treatment of metabolic disorders; gene therapy and prophylaxis products, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for the treatement of metabolic disorders; gene therapy and prophylaxis products, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, central nervous system diseases, brain diseases, brain stem diseases, spinal cord diseases, peripheral nervous system diseases, autonomous nervous system diseases, sensory organ diseases, infectious nervous system diseases, degenerative nervous system diseases, inherited nervous system diseases, vascular nervous system diseases, immune nervous system diseases, post-trauma nervous system diseases, Acute Spinal Cord Injury, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), Bell's Palsy, Brain Aneurysm, Brain Tumors, Epilepsy, Seizures, Guillain-Barré Syndrome, Head Injury, Headache, Lumbar Disc Disease (Herniated Disc), Meningitis, Multiple Sclerosis, Muscular Dystrophy, Normal Pressure Hydrocephalus, Parkinson's Disease, Stroke (Brain Attack), blood disorders, cancer, inflammation and inflammatory disorders, auto-immune diseases, vascular disorders, and single gene disorders; all the aforesaid as relating to metabolic disorders
(2) - Biological preparations for use in medical and clinical gene therapy and cell therapy; clinical medical reagents for use in gene therapy, gene diagnosis, and gene testing; pharmaceutical preparations, namely vaccines for use in gene therapy; all the aforementioned wares exclusively in the treatment of metabolic disorders; gene therapy and prophylaxis products, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for the treatement of metabolic disorders; gene therapy and prophylaxis products, namely gene-based biological preparations and medical reagents for use in gene delivery, gene transfer, gene regulation and gene modulation for the treatment of metabolic disorders, ocular disorders, central nervous system diseases, brain diseases, brain stem diseases, spinal cord diseases, peripheral nervous system diseases, autonomous nervous system diseases, sensory organ diseases, infectious nervous system diseases, degenerative nervous system diseases, inherited nervous system diseases, vascular nervous system diseases, immune nervous system diseases, post-trauma nervous system diseases, Acute Spinal Cord Injury, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), Bell's Palsy, Brain Aneurysm, Brain Tumors, Epilepsy, Seizures, Guillain-Barré Syndrome, Head Injury, Headache, Lumbar Disc Disease (Herniated Disc), Meningitis, Multiple Sclerosis, Muscular Dystrophy, Normal Pressure Hydrocephalus, Parkinson's Disease, Stroke (Brain Attack), blood disorders, cancer, inflammation and inflammatory disorders, auto-immune diseases, vascular disorders, and single gene disorders; all the aforesaid as relating to metabolic disorders
|